Literature DB >> 26873486

Bone marrow stromal cells induced activation of nuclear factor κB signaling protects non-Hodgkin's B lymphoma cells from apoptosis.

Tuo Su1, Jiakai Li2, Mingming Meng3, Sheng Zhao4, Yali Xu5, Xinmin Ding5, Hong Jiang5, Xiaorong Ma5, Jin Qian5, Wei Han1, Lixin Sun1, Xiaobin Li1, Zuojun Liu6, Lei Pan7, Xinying Xue8.   

Abstract

The microenvironment encompassing a variety of non-malignant cells in close proximity with malignant tumor cells has been well known to significantly affect the behavior of tumor cells. In this study, we therefore studied the mechanism of bone marrow stromal cells in protection of lymphoma cells from spontaneous apoptosis. We demonstrated that adhesion of the freshly isolated lymphoma B cells to bone marrow stromal cells or freshly isolated lymphoma stromal cells inhibited B cell spontaneous apoptosis in culture. This inhibition of apoptosis correlated with decreased cleavage of caspase-3/8 and increased activation of canonical and non-canonical NF-κB signaling pathway. In addition to BAFF signaling which has been reported as a functional determinant for B lymphoma cell survival in the bone marrow environment, we demonstrated RANKL from BMSCs works synergistically with BAFF to activate NF-κB signaling pathway and thus protects lymphoma B cells from spontaneous apoptosis.

Entities:  

Keywords:  Apoptosis; Bone marrow stromal cells; Non-Hodgkin’s B lymphoma cells; Nuclear factor κB signaling

Mesh:

Substances:

Year:  2016        PMID: 26873486     DOI: 10.1007/s13277-016-4860-1

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  38 in total

1.  Deregulation of MUM1/IRF4 by chromosomal translocation in multiple myeloma.

Authors:  S Iida; P H Rao; M Butler; P Corradini; M Boccadoro; B Klein; R S Chaganti; R Dalla-Favera
Journal:  Nat Genet       Date:  1997-10       Impact factor: 38.330

2.  Oncogenic CARD11 mutations in human diffuse large B cell lymphoma.

Authors:  Georg Lenz; R Eric Davis; Vu N Ngo; Lloyd Lam; Thaddeus C George; George W Wright; Sandeep S Dave; Hong Zhao; Weihong Xu; Andreas Rosenwald; German Ott; Hans Konrad Muller-Hermelink; Randy D Gascoyne; Joseph M Connors; Lisa M Rimsza; Elias Campo; Elaine S Jaffe; Jan Delabie; Erlend B Smeland; Richard I Fisher; Wing C Chan; Louis M Staudt
Journal:  Science       Date:  2008-03-06       Impact factor: 47.728

3.  Translocations activating IRF4 identify a subtype of germinal center-derived B-cell lymphoma affecting predominantly children and young adults.

Authors:  Itziar Salaverria; Claudia Philipp; Ilske Oschlies; Christian W Kohler; Markus Kreuz; Monika Szczepanowski; Birgit Burkhardt; Heiko Trautmann; Stefan Gesk; Miroslaw Andrusiewicz; Hilmar Berger; Miriam Fey; Lana Harder; Dirk Hasenclever; Michael Hummel; Markus Loeffler; Friederike Mahn; Idoia Martin-Guerrero; Shoji Pellissery; Christiane Pott; Michael Pfreundschuh; Alfred Reiter; Julia Richter; Maciej Rosolowski; Carsten Schwaenen; Harald Stein; Lorenz Trümper; Swen Wessendorf; Rainer Spang; Ralf Küppers; Wolfram Klapper; Reiner Siebert
Journal:  Blood       Date:  2011-04-12       Impact factor: 22.113

Review 4.  The noncanonical NF-κB pathway.

Authors:  Shao-Cong Sun
Journal:  Immunol Rev       Date:  2012-03       Impact factor: 12.988

Review 5.  Pathogenesis of human B cell lymphomas.

Authors:  Arthur L Shaffer; Ryan M Young; Louis M Staudt
Journal:  Annu Rev Immunol       Date:  2012-01-06       Impact factor: 28.527

6.  TNFAIP3/A20 functions as a novel tumor suppressor gene in several subtypes of non-Hodgkin lymphomas.

Authors:  Keiichiro Honma; Shinobu Tsuzuki; Masao Nakagawa; Hiroyuki Tagawa; Shigeo Nakamura; Yasuo Morishima; Masao Seto
Journal:  Blood       Date:  2009-07-16       Impact factor: 22.113

7.  Gene expression profiling of microdissected Hodgkin Reed-Sternberg cells correlates with treatment outcome in classical Hodgkin lymphoma.

Authors:  Christian Steidl; Arjan Diepstra; Tang Lee; Fong Chun Chan; Pedro Farinha; King Tan; Adele Telenius; Lorena Barclay; Sohrab P Shah; Joseph M Connors; Anke van den Berg; Randy D Gascoyne
Journal:  Blood       Date:  2012-09-05       Impact factor: 22.113

Review 8.  Proteases, extracellular matrix, and cancer: a workshop of the path B study section.

Authors:  Yves A DeClerck; Arthur M Mercurio; M Sharon Stack; Harold A Chapman; Mary M Zutter; Ruth J Muschel; Avraham Raz; Lynn M Matrisian; Bonnie F Sloane; Agnes Noel; Mary J Hendrix; Lisa Coussens; Martin Padarathsingh
Journal:  Am J Pathol       Date:  2004-04       Impact factor: 4.307

9.  Comparative gene expression profiling identifies common molecular signatures of NF-κB activation in canine and human diffuse large B cell lymphoma (DLBCL).

Authors:  Manikhandan A V Mudaliar; Ross D Haggart; Gino Miele; Grant Sellar; Karen A L Tan; John R Goodlad; Elspeth Milne; David M Vail; Ilene Kurzman; Daniel Crowther; David J Argyle
Journal:  PLoS One       Date:  2013-09-04       Impact factor: 3.240

10.  Inactivation of the PRDM1/BLIMP1 gene in diffuse large B cell lymphoma.

Authors:  Laura Pasqualucci; Mara Compagno; Jane Houldsworth; Stefano Monti; Adina Grunn; Subhadra V Nandula; Jon C Aster; Vundavally V Murty; Margaret A Shipp; Riccardo Dalla-Favera
Journal:  J Exp Med       Date:  2006-02-20       Impact factor: 14.307

View more
  4 in total

Review 1.  Emerging therapies provide new opportunities to reshape the multifaceted interactions between the immune system and lymphoma cells.

Authors:  M Pizzi; M Boi; F Bertoni; G Inghirami
Journal:  Leukemia       Date:  2016-06-08       Impact factor: 11.528

2.  BAFF is involved in macrophage-induced bortezomib resistance in myeloma.

Authors:  Jing Chen; Donghua He; Qingxiao Chen; Xing Guo; Li Yang; Xuanru Lin; Yi Li; Wenjun Wu; Yang Yang; Jingsong He; Enfan Zhang; Qing Yi; Zhen Cai
Journal:  Cell Death Dis       Date:  2017-11-02       Impact factor: 8.469

Review 3.  The RANK/RANKL/OPG system in tumorigenesis and metastasis of cancer stem cell: potential targets for anticancer therapy.

Authors:  Mekonnen Sisay; Getnet Mengistu; Dumessa Edessa
Journal:  Onco Targets Ther       Date:  2017-07-27       Impact factor: 4.147

4.  Acacetin Protects Myocardial Cells against Hypoxia-Reoxygenation Injury through Activation of Autophagy.

Authors:  Chong Liu; Minmin Zhang; Shenyi Ye; Chenliang Hong; Jiaxi Chen; Ruyue Lu; Bingjie Hu; Weijun Yang; Bo Shen; Zhengyi Gu
Journal:  J Immunol Res       Date:  2021-06-29       Impact factor: 4.818

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.